| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 12/22/2022 | — | Oppenheimer | Downgrades | Outperform → Perform | |
| 09/12/2022 | 290.62% | Morgan Stanley | $8 → $5 | Maintains | Equal-Weight |
| 08/25/2022 | 1071.87% | Alliance Global Partners | → $15 | Initiates Coverage On | → Buy |
| 08/23/2022 | 368.75% | Truist Securities | $10 → $6 | Maintains | Hold |
| 06/22/2022 | 1071.87% | HC Wainwright & Co. | → $15 | Initiates Coverage On | → Buy |
| 04/06/2022 | — | Truist Securities | Downgrades | Buy → Hold | |
| 01/28/2022 | 603.12% | Oppenheimer | → $9 | Initiates Coverage On | → Outperform |
| 11/24/2021 | 603.12% | Morgan Stanley | → $9 | Initiates Coverage On | → Equal-Weight |
| 10/19/2021 | 837.5% | Truist Securities | → $12 | Initiates Coverage On | → Buy |
What is the target price for Celularity (CELU)?
There is no price target for Celularity
What is the most recent analyst rating for Celularity (CELU)?
There is no analyst for Celularity
When is the next analyst rating going to be posted or updated for Celularity (CELU)?
There is no next analyst rating for Celularity
Is the Analyst Rating Celularity (CELU) correct?
There is no next analyst rating for Celularity